Schonfeld Strategic Advisors LLC Seagen Inc. Transaction History

Schonfeld Strategic Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $5.11 Million - $5.77 Million	26,695 Added 287.63%	35,976 $7.63 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $1.8 Million - $1.98 Million	-9,609 Reduced 50.87%	9,281 $1.79 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $8.87 Million - $14.1 Million	-69,510 Reduced 78.63%	18,890 $3.82 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $3.88 Million - $4.6 Million	33,040 Added 59.68%	88,400 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $3.04 Million - $4.04 Million	22,448 Added 68.21%	55,360 $7.58 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $565,376 - $931,798	-5,196 Reduced 13.63%	32,912 $5.82 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $531,427 - $701,327	-4,443 Reduced 10.44%	38,108 $5.49 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $4.77 Million - $6.38 Million	33,451 Added 367.59%	42,551 $6.58 Million
Q3 2021 Nov 16, 2021	SELL	$142.45 - $169.82 $4.92 Million - $5.86 Million	-34,504 Reduced 79.13%	9,100 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $4.11 Million - $4.9 Million	30,404 Added 230.33%	43,604 $6.89 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $1.82 Million - $2.52 Million	13,200 New	13,200 $1.83 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.